Showing results (161-170 of 287) with videos related to

Sort By:
Pageof 29
Gut|February 15, 2011
A randomised trial of sheathed versus standard forceps for obtaining uncontaminated biopsy specimens of microbiota from the terminal ileumManeesh Dave, Laura A Johnson, Seth T Walk, et al.
Bio/Technology (Nature Publishing Company)|January 1, 1996
Production of a recombinant bovine enterokinase catalytic subunit in the methylotrophic yeast Pichia pastorisL A Vozza, L Wittwer, D R Higgins, et al.
Crohn'S & Colitis 360|February 13, 2023
Safety, Pharmacokinetics, and Efficacy of Olorinab, a Peripherally Acting, Highly Selective, Full Agonist of the Cannabinoid Receptor 2, in a Phase 2a Study of Patients With Chronic Abdominal Pain Associated With Crohn's DiseaseBruce R Yacyshyn, Stephen Hanauer, Preston Klassen, et al.
Digestive Diseases and Sciences|April 13, 2018
Systemic Inflammatory Responses in Ulcerative Colitis Patients and Clostridium difficile InfectionJulajak Limsrivilai, Krishna Rao, Ryan W Stidham, et al.
Alimentary Pharmacology & Therapeutics|January 22, 2019
Long-term safety and tolerability of oral tofacitinib in patients with Crohn's disease: results from a phase 2, open-label, 48-week extension studyJulián Panés, Geert R D'Haens, Peter D R Higgins, et al.
The American Journal of Gastroenterology|December 13, 2017
Defining an Optimal Adherence Threshold for Patients Taking Subcutaneous Anti-TNFs for Inflammatory Bowel DiseasesShail M Govani, Mohamed Noureldin, Peter D R Higgins, et al.
Gastroenterology|July 26, 2011
Ultrasound elasticity imaging for detecting intestinal fibrosis and inflammation in rats and humans with Crohn's diseaseRyan W Stidham, Jingping Xu, Laura A Johnson, et al.
The American Journal of Gastroenterology|October 31, 2013
Machine learning algorithms outperform conventional regression models in predicting development of hepatocellular carcinomaAmit G Singal, Ashin Mukherjee, B Joseph Elmunzer, et al.
Digestive Diseases and Sciences|October 26, 2024
Self-Efficacy, Patient Activation, and the Burden of Inflammatory Bowel Disease on Patients' Daily LivesJessica L Sheehan, LaVana Greene-Higgs, Kenneth Resnicow, et al.
Mucosal Immunology|February 12, 2019
Flagellin-mediated activation of IL-33-ST2 signaling by a pathobiont promotes intestinal fibrosisJin Imai, Sho Kitamoto, Kohei Sugihara, et al.
Pageof 29